Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

749
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
749
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

516
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
516

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Donanemab treatment effect by baseline tau burden and disease severity: Observations from the TRAILBLAZER-ALZ 2 trial.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same author

Psychometric Evidence for an Augmented PDAQ for Improved Measurement of Cognition-Related IADLs in Parkinson's Disease.

Movement disorders clinical practice·2026
Same author

Generating synthetic tau-PET scans in Alzheimer's disease from MRI, blood biomarkers and demographics with deep learning.

medRxiv : the preprint server for health sciences·2026
Same author

Interchangeability of CSF and PET to identify Alzheimer's disease pathology.

Alzheimer's & dementia (Amsterdam, Netherlands)·2026
Same author

Neuropathological correlates of age and sex differences in 18F-flortaucipir PET.

Brain : a journal of neurology·2026
Same author

Interchangeability of blood-based biomarkers and PET to identify Alzheimer's disease pathology.

Alzheimer's & dementia (Amsterdam, Netherlands)·2026

相关实验视频

Updated: Jan 7, 2026

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies
07:20

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies

Published on: January 28, 2014

37.1K

生物标志物 生物标志物

Kay Hoong Chow1, Tongrong Wang2, Ilke Tunali3

  • 1Eli Lilly and Company, Bracknell, Berkshire, United Kingdom.

Alzheimer's & dementia : the journal of the Alzheimer's Association
|December 25, 2025
PubMed
概括
此摘要是机器生成的。

这项研究模拟了几十年来粉样蛋白斑块的积累,揭示了年龄和APOE4基因型作为关键因素. 了解这种进展有助于阿尔茨海默病 (AD) 预防策略和临床试验设计.

更多相关视频

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
07:35

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

7.9K
Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans
08:14

Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans

Published on: April 28, 2023

702

相关实验视频

Last Updated: Jan 7, 2026

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies
07:20

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies

Published on: January 28, 2014

37.1K
Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
07:35

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

7.9K
Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans
08:14

Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans

Published on: April 28, 2023

702

科学领域:

  • 神经科学是一个神经科学.
  • 生物统计学 生物统计学
  • 老年学是指老年学的学科.

背景情况:

  • 粉样质斑块的积累是阿尔茨海默病 (AD) 的标志,可能会开始临床前阶段.
  • 了解粉样蛋白积累的自然速率对于开发有效的AD预防策略至关重要.
  • 以前的研究表明,粉样斑块的积累可能遵循由各种因素影响的指数增长模式.

研究的目的:

  • 使用自然历史数据建立长期 (10+年) 粉样斑块积累模型.
  • 为了确定影响不同群体粉样斑块进展的重要因素.
  • 为AD预防试验的设计和解释提供信息.

主要方法:

  • 利用了非线性混合效应建模与逐步共变量选择和人工智能.
  • 分析了来自大型队列的数据:ADNI (N=1745),BioFINDER (N=265) 和学习 (N=4492).
  • 评估了线性,指数和非线性模型,以估计积累率和可变性.

主要成果:

  • 确定了年龄,基线粉样质斑块水平和APOE4基因型作为斑块积累的重要预测因素.
  • 观察到60岁左右的粉样质斑块急剧增加,随后在年龄较大时的和.
  • 他指出,这些变化在APOE4载体中更早地开始.

结论:

  • 开发了几十年来粉样质斑块积累的预测模型,适用于AD临床试验设计.
  • 强调预防粉样蛋白积累可以避免临床前的AD和随后的认知衰退.
  • 强调了该模型在解释针对粉样蛋白的新型AD治疗干预措施中的实用性.